Compare FTW & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FTW | AUTL |
|---|---|---|
| Founded | N/A | 2014 |
| Country | | United Kingdom |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.2M | 433.8M |
| IPO Year | 2024 | 2025 |
| Metric | FTW | AUTL |
|---|---|---|
| Price | $12.40 | $1.66 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 89.6K | ★ 1.4M |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $10,120,000.00 |
| Revenue This Year | N/A | $670.78 |
| Revenue Next Year | N/A | $80.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 496.00 |
| 52 Week Low | $10.40 | $1.11 |
| 52 Week High | $13.75 | $2.70 |
| Indicator | FTW | AUTL |
|---|---|---|
| Relative Strength Index (RSI) | 76.60 | 55.47 |
| Support Level | N/A | $1.65 |
| Resistance Level | N/A | $1.69 |
| Average True Range (ATR) | 0.61 | 0.11 |
| MACD | 0.20 | 0.03 |
| Stochastic Oscillator | 57.81 | 51.99 |
EQV Ventures Acquisition Corp is a blank check company.
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.